Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Deferred Income Tax

The difference between tax expense recognized and tax actually paid in cash during the period.

Spectral Medical Inc.TSX: EDT.TO

Deferred Income Tax · Q1 FY2026 · quarter ended Mar 2026

Deferred income tax outflow grows to CA$0

Q1 FY2026 deferred income tax was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month deferred income tax was CA$0.

Context

  • Deferred income tax amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Deferred income tax increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly deferred income tax holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearDec 2025
CA$0— YoY
LTMMar 2026
CA$0— YoY
Deferred Income Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Income Tax history

CAD · from the cash flow

Latest · FY2025
0 CAD
Year-over-year change
—

Deferred Income Tax vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred income tax is compared through growth and share of revenue rather than absolute size.
  • Deferred income tax amounts to 0.0% of revenue for EDT.TO, versus a peer median of 0.0%.
EDT.TO Competitors
Deferred Income Tax for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$10.64M USD+43.2%-10.2%20.9%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$225.4K CAD+12.1%—0.3%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$107.47K CAD-98.5%—0.0%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$55K CAD+101.7%—0.0%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$0 CAD——0.0%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$0 USD———
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$0 USD——0.0%
PRN.TOProfound Medical Corp.LTM Mar 2026$0 USD——0.0%
Peer median (excluding EDT.TO) —+27.6%-10.2%0.0%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.79M)(11.25M)(15.66M)(15.4M)(47.69M)
Depreciation & Amortization294K272K218K251K250K
Deferred Income Tax00000
Stock-Based Compensation1.26M1.2M1.49M1.68M2.12M
Change in Working Capital(1.76M)579K(406K)1.01M(189K)
Accounts Receivables55K(877K)870K(265K)246K
Inventory(51K)(47K)(26K)137K(148K)
Accounts Payables(1.11M)1.65M(267K)(51K)(265K)
Other Working Capital(656K)(142K)(983K)1.19M(22K)
Other Non-Cash Items288K(698K)3.64M3.64M33.88M
Operating Cash Flow(8.7M)(9.9M)(10.72M)(8.82M)(9.52M)
Capital Expenditures(483K)(33K)(185K)(27K)(195K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities158K0000
Investing Cash Flow(325K)(33K)(185K)(27K)(195K)
Debt Repayment(113K)3.71M3.93M9.74M9.67M
Common Stock Issued10M4.03M01.15M3.4M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.28M1.72M1.51M(2.02M)(155K)
Financing Cash Flow12.17M9.46M5.44M8.88M12.91M
Effect of Forex Changes(56K)0000
Net Change in Cash3.08M(476K)(5.46M)36K1.08M
Free Cash Flow(9.18M)(9.93M)(10.91M)(8.85M)(9.72M)

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.